PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer.
DNA ploidy
PTEN
machine learning
prostate cancer
tumor heterogeneity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Aug 2021
26 Aug 2021
Historique:
received:
03
08
2021
revised:
23
08
2021
accepted:
24
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
Machine learning (ML) is expected to improve biomarker assessment. Using convolution neural networks, we developed a fully-automated method for assessing PTEN protein status in immunohistochemically-stained slides using a radical prostatectomy (RP) cohort (
Identifiants
pubmed: 34503100
pii: cancers13174291
doi: 10.3390/cancers13174291
pmc: PMC8428363
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Norges Forskningsråd
ID : 259204
Organisme : Helse Sør-Øst RHF
ID : 2013133
Références
Clin Cancer Res. 2019 Feb 1;25(3):928-936
pubmed: 30037818
Nature. 2016 Oct 05;538(7623):20-23
pubmed: 27708329
Br J Cancer. 2017 Jul 25;117(3):367-375
pubmed: 28618431
World J Urol. 2018 Sep;36(9):1495-1500
pubmed: 29679140
Clin Cancer Res. 2016 Jun 1;22(11):2802-11
pubmed: 26813356
Ann Diagn Pathol. 2014 Dec;18(6):333-42
pubmed: 25263387
Nat Rev Urol. 2018 Aug;15(8):475-482
pubmed: 29713007
J Natl Cancer Inst. 2015 Nov 27;108(2):
pubmed: 26615022
Lancet Oncol. 2020 Feb;21(2):233-241
pubmed: 31926805
Nat Med. 2019 Jan;25(1):44-56
pubmed: 30617339
Am J Surg Pathol. 2005 Sep;29(9):1228-42
pubmed: 16096414
Eur Urol. 2011 Jun;59(6):893-9
pubmed: 21388736
Nat Rev Clin Oncol. 2016 May;13(5):291-304
pubmed: 26598944
J Natl Cancer Inst. 2007 Jul 4;99(13):998-1003
pubmed: 17596575
J Urol. 2011 Mar;185(3):869-75
pubmed: 21239008
Lancet Oncol. 2020 Feb;21(2):222-232
pubmed: 31926806
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
Mod Pathol. 2021 Feb;34(2):478-489
pubmed: 32884130
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
BMC Cancer. 2018 Jan 2;18(1):8
pubmed: 29295717
IEEE Trans Pattern Anal Mach Intell. 2020 Feb;42(2):386-397
pubmed: 29994331
Oncotarget. 2017 Jul 10;8(39):65566-65576
pubmed: 29029453
Lancet Oncol. 2019 May;20(5):e253-e261
pubmed: 31044723
Br J Cancer. 2013 Jun 25;108(12):2582-9
pubmed: 23695019
Eur Urol. 2013 Aug;64(2):193-8
pubmed: 23522911
Eur Urol. 2021 Feb;79(2):263-282
pubmed: 33039206
J Urol. 2010 Feb;183(2):433-40
pubmed: 20006878
J Natl Cancer Inst. 2018 Aug 1;110(8):803-811
pubmed: 29873743
J Urol. 2001 Apr;165(4):1146-51
pubmed: 11257657
Eur Urol. 2019 Sep;76(3):268-272
pubmed: 31128968
Lancet. 2020 Feb 1;395(10221):350-360
pubmed: 32007170
IEEE Trans Med Imaging. 2020 Feb;39(2):534-542
pubmed: 31398111
Hum Pathol. 2009 Apr;40(4):471-7
pubmed: 19128819
J Natl Cancer Inst. 2009 Jun 16;101(12):878-87
pubmed: 19509351
NPJ Digit Med. 2019 May 30;2:43
pubmed: 31304389
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
EMBO Rep. 2012 Jun 01;13(6):528-38
pubmed: 22595889
Nat Rev Cancer. 2021 Mar;21(3):199-211
pubmed: 33514930
Eur Urol. 2008 Apr;53(4):767-75; discussion 775-6
pubmed: 18060681
J Urol. 1995 Jul;154(1):131-8
pubmed: 7539857
J Natl Cancer Inst. 2020 Nov 1;112(11):1098-1104
pubmed: 32129857
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
J Clin Oncol. 2020 May 1;38(13):1474-1494
pubmed: 31829902
J Urol. 2010 Mar;183(3):952-7
pubmed: 20083260
J Urol. 2016 Jun;195(6):1754-9
pubmed: 26721226
Eur Urol. 2020 Feb;77(2):191-198
pubmed: 31439369
Histopathology. 2016 Sep;69(3):441-9
pubmed: 27028587
Cancer Lett. 2020 Feb 28;471:61-71
pubmed: 31830558
IEEE Trans Med Imaging. 2019 Feb;38(2):617-628
pubmed: 30183623